Form 4: Revvity Director Reports Planned Stock Sale

Revvity Director Michelle McMurry-Heath reported a planned sale of 600 common shares under a 10b5-1 plan at a weighted average price of $97.26.

Summary

• Michelle McMurry-Heath, a Director of Revvity, Inc. (RVTY), reported a planned transaction involving the disposition of common stock.
• The transaction, scheduled for February 23, 2026, involves the sale of 600 shares of common stock.
• The shares are to be sold at a weighted average price of $97.26 per share, with individual sale prices ranging from $97.15 to $97.35.
• Following this planned transaction, McMurry-Heath will beneficially own 4,233 shares of Revvity common stock.
• This transaction is being made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, the small number of shares and the disclosure of a 10b5-1 plan suggest a routine transaction for personal financial planning rather than a bearish signal.

Negatives

• A director's planned sale of shares, even under a 10b5-1 plan, can sometimes be perceived by the market as a slight reduction in insider confidence, although it is often for personal financial planning.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 plan, are common occurrences in the market and often reflect personal financial planning, such as diversification or liquidity needs, rather than a specific negative outlook on the company's future. Revvity operates in the life sciences and diagnostics industry, where executive compensation frequently includes equity, leading to periodic sales.

Stakeholder Impact

• Shareholders: The planned sale of shares by a director could be interpreted by some shareholders as a minor signal, though the small volume and the 10b5-1 plan mitigate any significant negative implications.

Key Dates

Recommendation

The planned sale of 600 shares by a director, executed under a 10b5-1 plan, is a minor event for a company of Revvity's market capitalization and does not provide sufficient new information to warrant a change in investment thesis. Investors should maintain their current position and focus on broader company fundamentals and industry trends.

Keywords

Revvity, RVTY, Insider Transaction, Form 4, Stock Sale, Director, Michelle McMurry-Heath, 10b5-1 Plan